Combination chemotherapy with nitrogen mustard, vincristine, procarbazine and prednisone in previously treated patients with Hodgkin's disease.
D000293:Adolescent; D000328:Adult; D000963:Antimetabolites / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects; D001565:Benzoates / Q000627:therapeutic use; D002648:Child; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000532:radiotherapy; D006801:Humans; D007970:Leukopenia / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use*; D014750:Vincristine / Q000627:therapeutic use*
D000963:Antimetabolites; D000970:Antineoplastic Agents; D001565:Benzoates; D009588:Nitrogen Mustard Compounds; D014750:Vincristine; D011241:Prednisone